Leaderboard

En | De
Sie sind hier: Gynäkologie » Mammae 31. Mai 2026
Suchen
medline.ch
Mammae
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Fortpflanzung
Genitale Erkrankungen
Infertilität
Mammae
Menopause
Schwangerschaft
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 10916  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 218316  
   
Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancer.
Clin Exp Med
Javadian M, Zeinali T, Rajabi M, Mehrasa Z, Boogari M, Ramezani F, Samaeinasab S, Mahmoudi Z, Hakimi H, Sabzehban R, Najafi K, Esmaeili K, Khaksarhaghani Z, Tahmasebi S, Rezaei R.
PMID: 42218707 [PubMed - as supplied by publisher]


Small interfering RNA (siRNA)-based targeting breast cancer therapy.
Discov Oncol
Talebi A, Khorrami A, Oruji F, Shabani S, Hajazimian S, Nasiri H, Khansalar S, Isazadeh A, Akbari M.
PMID: 42218706 [PubMed - as supplied by publisher]


Premedication with steroids in breast cancer - supportive treatment or tumour growth promotion?
Magy Onkol
Butz H, Oláh A, Patócs A.
PMID: 42218678 [PubMed - indexed for MEDLINE]


Development and external validation of multiple machine learning-based models for breast cancer-specific survival prediction in postoperative patients with invasive breast cancer: a study based on the SEER database and an external cohort.
BMC Cancer
Liu S, Liu J, Li D, Mo Q.
PMID: 42218459 [PubMed - as supplied by publisher]


Nipple aspirate fluid as a proximal breast liquid biopsy platform: advancing precision risk management in breast cancer.
Clin Proteomics
Guo S, Liu J, Zheng H, Wu X.
PMID: 42218386 [PubMed - as supplied by publisher]


Multi-ancestry transcriptome-wide association studies uncover insights into breast cancer genetics and biology.
Nat Commun
Ping J, Jia G, Cai Q, Guo X, Wang J, Tao R, Li B, Bauer JA, Xie Y, Ambs S, Barnard ME, Chen Y, Choi JY, Gao YT, Garcia-Closas M, Gu J, Hu JJ, Iwasaki M, John EM, Kweon SS, Li CI, Matsuda K, Matsuo K, Nathanson KL, Nemesure B, Olopade OI, Pal T, Park SK, Park B, Press MF, Sanderson M, Sandler DP, Yao S, Zheng Y, Ahearn T, Brewster AM, Falusi A, Hennis AJM, Ito H, Kubo M, Lee ES, Makumbi T, Mapoko BSE, Noh DY, O'Brien KM, Ojengbede O, Olshan AF, Park MH, Reid S, Yamaji T, Zirpoli G, Butler EN, Huang M, Low SK, Obafunwa J, Weinberg CR, Zhang H, Zhao H, Ambrosone CB, Cote ML, Huo D, Haiman CA, Kang D, Palmer JR, Troester MA, Shu XO, Long J, Zheng W.
PMID: 42218145 [PubMed - as supplied by publisher]


Unravelling the mystery of hypoxia-induced miRNAs in breast cancer: A molecular cross-talk driving tumour progression and therapy resistance.
Mol Aspects Med
Sharma N, Yadav V, Sinha S, Kumari L, Sethi A, Marcus S, Pratap Singh M, Kaur S, Garg N, Pathak A, Vellingir B, Kumar S.
PMID: 42217842 [PubMed - as supplied by publisher]


Circular RNA-centered regulatory networks in breast cancer: From ceRNA crosstalk to immune microenvironment reprogramming.
Gene
Wang J, Tian Y.
PMID: 42217688 [PubMed - as supplied by publisher]


Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(†).
Ann Oncol
de Azambuja E, Barrios CH, Bartsch R, Curigliano G, Dent R, Gennari A, Loi S, Paluch-Shimon S, Pistilli B, Saura C, Schmid P, Spanic T, Toi M, Tolaney SM, Harbeck N, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
PMID: 42217581 [PubMed - as supplied by publisher]


Estimating overall survival for breast cancer in Ghana: A time-to-event meta-analysis.
Cancer Epidemiol
Darko K, Ajayi-Majebi G, Marfo K, Agbemavi-Kudufia LA, Hagan HR, Nsaful J.
PMID: 42217387 [PubMed - as supplied by publisher]


Exploring shear-wave elastography and apparent diffusion coefficient in breast lesion characterization: diagnostic accuracy and inter-modality correlation.
Radiol Med
Aricò FM, Portaluri A, Arena P, Sofia C, Condorelli E, Catanzariti F, Zuccalà V, Berretta M, Ascenti G, Marino MA.
PMID: 42217149 [PubMed - as supplied by publisher]


Single axillary incision for minimal access (endoscopic or robotic-assisted) nipple sparing mastectomy: axillary crease or lateral chest wall incision?
J Robot Surg
Koh CH, Kao WP, Periasammy D, Lee YY, Lai HW.
PMID: 42216981 [PubMed - indexed for MEDLINE]


DNA Damage Repair Pathways and Targeted Therapy for Doxorubicin-Resistant Breast Cancer.
Front Biosci (Landmark Ed)
Wu Y, Li X, Wang W, Liu SB, Li X.
PMID: 42216534 [PubMed - indexed for MEDLINE]


From Technological Innovation to Clinical Translation: Progress and Challenges in 3D Bioprinting for the Development of Breast Cancer Bone Metastasis Models.
Adv Healthc Mater
Miao L, Jiang D, Zhang X, Kang Y.
PMID: 42216436 [PubMed - as supplied by publisher]


Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.
Cancer
Ballinger TJ, Zhao F, Jiang G, Shen F, Cella D, Peipert JD, Miller KD, Wolff AC, DeMichele AM, Schneider BP, Wagner LI.
PMID: 42216434 [PubMed - indexed for MEDLINE]


False-positive mammogram has a negative impact on quality of life: A cross-sectional study among Jordanian women at King Abdullah University Hospital.
Medicine (Baltimore)
Gharaibeh MM, Elobeid EA, Ahmmed SM, Fataftah JZ, Khasawneh RA, Rawashdeh MA, El-Heis SM, Gharaibeh SI, Elheis MA.
PMID: 42216337 [PubMed - indexed for MEDLINE]


The causal role of plasma metabolites in breast cancer susceptibility mediated by immune cells: A two-sample Mendelian randomization analysis.
Medicine (Baltimore)
Sun Z, Ge F, Duan W, Qian J, Chen L.
PMID: 42216331 [PubMed - indexed for MEDLINE]


Bioconjugates for breast cancer theranostics: improving target selectivity and treatment efficacy.
Expert Opin Drug Deliv
Jain N, Kaul S, Verma R, Sharma A, Pandey M, Chaudhary A, Nagaich U.
PMID: 42216243 [PubMed - as supplied by publisher]


Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2- metastatic breast cancer: a multicenter prospective cohort study.
Breast Cancer Res
Ishikawa T, Uemura Y, Seki H, Kitada M, Saito T, Yamada K, Takao S, Takabatake D, Yokota T, Kitahara M, Kikawa Y, Yamada A, Toh U, Nishimura H, Kaise H, Yamagami K, Nishimura R, Taira N, Narui K, Mukai H.
PMID: 42216212 [PubMed - as supplied by publisher]


Atezolizumab versus pembrolizumab in the treatment of advanced triple-negative breast cancer: a Bayesian network meta-analysis of ITT and PD-L1 positive populations.
BMC Cancer
Wiguna IGWW, Sadeva IGKA, Mamangdean CT, Mahayana NPK, Khanaruksombat S, Thu MS, Putri PMWS, Tungga KMK, Kepakisan ABN, Arta KIP, Pratama RP, Hirankarn N.
PMID: 42215937 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 218316    Seite 1 von 10916  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1